Topics: modelling, forecasting, measurement errors, data estimation, general equilibrium models, COMBINING DATA, ANALYTIC TECHNIQUES, Wage-earnings, Company failure, hysteresis

Topics: Public Sector Economics, Public Sector Analysis, Public Sector, Public Finance, Public Goods, Public debts, Public Budget, Public Expenditure, Budgeting, Externalities, Market Failure, Cost-Benefit Analysis

Topics: CELLULAR INJURY, ACUTE INFLAMMATION, Inflammation, Tissue Repair, wound healing, regeneration, healing, Circulatory Pathology, edema, Genetic Disorders, Immunopathology, hypersensitivity reactions, Amyloidosis, amyloid, neoplasia, carcinogenic agents, carcinogenesis, cancer, Skin Pathology, pigmentation, melanocytic tumors, epidermal lesions, dermal lesions, malignant tumors, Red Blood Cell Pathology, Anemia, red blood cell morphology, microcytic anemia, normocytic anemia, macrocytic anemia, polycythemia vera, Vascular Pathology, vasculitides, Raynaud disease, arteriosclerosis, hypertension, aneurysm, arteriovenous fistula, venous disease, vascular neoplasms, Cardiac Pathology, ISCHEMIC HEART DISEASE, Respiratory Pathology, congenital cystic lung lesions, atelectasis, pulmonary infections, sarcoidosis, obstructive versus restrictive lung disease, pulmonary neoplasia, laryngeal neoplasia, pleural cavity, Renal Pathology, nephritic syndrome, nephrotic syndrome, secondary glomerulonephritis, chronic glomerulonephritis, tubulointerstitial nephritis, acute tubular injury, urolithiasis, chronic renal failure, ureteral disorders, urinary bladder pathology, Gastrointestinal Tract Pathology, gastric lymphoma, Pancreatic Pathology, Gallbladder Pathology, Biliary Tract Pathology, Liver Pathology, jaundice, cirrhosis, viral hepatitis, amebic liver abscess, alcoholic liver disease, hemodynamic liver disease, liver tumors, Central Nervous System Pathology, blood brain barrier, cerebrovascular disease, CNS trauma, brain herniation, perinatal brain injury, demyelinating disorders, degenerative disorders, dementing disorders, CNS tumors, Hematopoetic Pathology, White Blood Cell Disorders, Lymphoid Neoplasms, Myeloid Neoplasms, mature B-cell neoplasm, peripheral T-cell neoplasm, natural killer cell neoplasm, Hodgkin lymphoma, acute leukemia, B and T lymphoblastic lymphoma, T lymphoblastic leukemia, B lymphoblastic leukemia, mast cell diseases, Female Genital Pathology, Breast Pathology, mastitis, gynecomastia, Male Pathology, testicular cancer, prostate disease, prostate disease

Topics: Drug Therapy, Pharmacokinetics, Drug–Receptor Interactions, Pharmacodynamics, Autonomic Nervous System, Cholinergic Agonists, Cholinergic Antagonists, Adrenergic Agonists, Adrenergic Antagonists, Neurodegenerative Diseases, Anxiolytic drugs, Hypnotic Drugs, Antidepressants, Antipsychotic Drugs, Anesthetics, Opioids, CNS Stimulants, Antihypertensives, diuretics, Heart Failure, epilepsy, Antiarrhythmics, Antianginal Drugs, Anticoagulants, Antiplatelet Agents, Hyperlipidemia, Endocrine System, Pituitary, Thyroid, diabetes, estrogen, androgen, adrenal hormone, bone metabolism, Chemotherapeutic Drugs, Antimicrobial Therapy, Cell Wall Inhibitors, Protein Synthesis Inhibitors, Quinolones, Folic Acid Antagonists, Urinary Tract Antiseptics, Antimycobacterial Drugs, Antifungal Drugs, Antiviral Drugs, Anticancer Drugs, Immunosuppressants, Histamine, Serotonin, Anti-inflammatory Agents, Antipyretic Agents, Analgesic Agents, Gastrointestinal drugs, Antiemetic Drugs, Urologic Disorders, anemia, Dermatologic Disorders, Clinical Toxicology, drugs of abuse, Antiprotozoal Drugs, Anthelmintic Drugs

Topics: Pharmacogenomics, Pharmacoepidemiology, DRUG SPECIFICITY, receptor classification, drug concentration, drug effect, spare receptors, COMPETITIVE ANTAGONISM, Irreversible Competitive Antagonism, Partial Agonists, Constitutive Receptor Activation, Inverse Agonists, two-state receptor model, Biased Agonism, Allosteric Modulation, Chemical Antagonism, Pharmacokinetic Antagonism, Receptor–Response Linkage, Physiological Antagonism, Desensitisation, Tolerance, Altered Drug Metabolism, Binding Reaction, Drug–Receptor Interactions, Receptor mechanisms, Ion Channels, Enzymes, Receptor Proteins, Receptor Heterogeneity, Ligand-Gated Ion Channels, Gating Mechanism, G Protein–Coupled Receptors, Proteinase-Activated Receptors, G proteins, phospholipase C, inositol phosphate system, Inositol phosphates, intracellular calcium, Diacylglycerol, protein kinase, MAP kinase system, GPCR desensitisation, Biopharmaceuticals, Chemical Mediators, Presynaptic Modulation, Postsynaptic Modulation, Cholinergic transmission, Nicotinic Receptors, Acetylcholine, Muscarinic Agonists, Muscarinic Antagonists, Ganglion Stimulants, Ganglion-Blocking Drugs, Neuromuscular-Blocking Drugs, Non-Depolarising Blocking Agents, Depolarising Blocking Agents, Cholinesterase Reactivation, Noradrenergic transmission, Adrenoceptor Agonists, α-Adrenoceptor antagonists, 5-Hydroxytryptamine, migraine, Adenosine, purine, Histamine, local hormone, Eicosanoids, Prostanoids, Leukotrienes, Platelet-Activating Factor, Bradykinin, peptide, Neuropeptides, Cytokine, Interferon, Cannabinoids, Endocannabinoids, Nitric oxide, Ischaemic Heart Disease, Antidysrhythmic Drugs, Myocardial Contraction, Anti-Anginal Drugs, Organic Nitrates, Calcium Antagonists, Endothelin, Vasoactive Drugs, Vasodilator Drugs, heart failure, Atherosclerosis, lipoprotein metabolism, Lipoprotein Transport, Lipid-Lowering Drugs, Fibrates, Haemostasis and thrombosis, Blood Coagulation, Warfarin, Platelet Adhesion, Platelet Activation, Antiplatelet Drugs, Adenosine Receptor Antagonists, Fibrinolysis, Thrombolysis, Fibrinolytic Drugs

Topics: Health Care Financing Reforms, Markets, Health Care, health care financing, Funding Health Care, health care systems, health care market failure, Consumer Moral Hazard, Doctor Moral Hazard, Moral Hazard, Countering Consumer Moral Hazard, Countering Doctor Moral Hazard, Equity, Health Care Budget

Topics: Health Economics, Economic Valuation of Life, Economic Valuation of Life Health, Production of Health, Health Goods, Market Failure, Optimal Health Insurance Contracts, Risk Selection in Health Insurance Markets, Medical Services, Hospital Services, Hospital Efficiency, Medical Care, Delivery of Medical Care, Pharmaceuticals, Market for Pharmaceuticals, Political Economy of Health Care, Health Care System

Topics: Small Business Finance, Small Business, Nigerian Financial System, Nigerian Money Market, Nigerian Capital Market, Nigerian Securities and Exchange Commission, central bank of Nigeria, Types of Finance, financing small business, Business Plans, Analysis of Market Opportunities, Failure of Small Business, Success of Small Business, Roles of Small Business in Economic Development

Topics: Entrepreneurship, practicing Entrepreneurship, Entrepreneurial Mindset, Creating Opportunities, Developing Opportunities, Creating New Opportunities, Recognizing New Opportunities, Design Thinking, Building Business Models, Business Models, Developing Customers, Testing, Experimenting, Developing Networks, Building Teams, Evaluating on Opportunities, Acting on Opportunities, Creating Revenue Models, Planning for Entrepreneurs, planning, Anticipating Failure, Bootstrapping, Crowdfunding, Financing Startups, Financial Statements, stratup Projections, Engaging Customers, Marketing, Social Entrepreneurship

Topics: Decision Support Systems, Information Systems, Decision-Making Process, decisions, knowledge, Decision Making, Sensemaking, Data Quality, Decision Makers, Decision Support, Knowledge Management, Integrated Document Management, Online Analytical Processing, Spreadsheet-Based Decision Support Systems, Multi-Criteria Decision Support, Web-Based Decision Support, MULTIPARTICIPANT DECISION SUPPORT SYSTEMS, Group Decision Support Systems, Organizational Decision Support Systems, Negotiation Support, E-negotiation Systems, INTELLIGENT DECISION SUPPORT SYSTEMS, Artificial Neural Networks, Data Mining, Data Fusion, Enhanced Decision Support, Adaptive Decision Support Systems, COMPUTER-BASED DECISION SUPPORT, Decision Support Systems Failure